Additional file 6: of An analysis of deficiencies in the data of interventional drug trials registered with Clinical Trials Registry - India

The percentage of trials with errors, in 3-year time periods, for the several categories of errors. a The percentage of trials with errors, in 3-year time periods, for the following categories of errors: (i) Type of Study: Large number of categories, (ii) Errors in determining the unambiguously Indian trials, (iii) Errors in determining the unambiguously Multinational trials, (iv) Indian trials: Interventional cases with Phase listed as PMS, (v) Redefined Indian trials: Type of Trial was PMS, but Phase of Trial was Phase 4, and (vi) Redefined Indian trials: Type of Trial was BA/BE, but Phase was 1, 1/2, 2, 2/3, 3, 3/4, or 4. Columns of data using redefined datasets are shaded. b The percentage of trials with errors, in 3-year time periods, for the following categories of errors: (i) Indian trials: Incorrect listing of cities, (ii) Multinational trials: Incorrect listing of cities, (iii) Indian trials: PI names listed as null, (iv) Multinational trials: PI names listed as null, (v) Redefined Indian trials: Type of Study was NA, but Phase was 1, 1/2, 2, 2/3, 3, 3/4, or 4, and (vi) Indian trials: Primary sponsor name â nilâ . Columns of data using redefined datasets are shaded. c The percentage of trials with errors, in 3-year time periods, for the following categories of errors: (i) Indian trials: State of trial site missing, (ii) Multinational trials: State of trial site missing, (iii) Indian trials: More ethics committees than trial sites, and (iv) Multinational trials: More ethics committees than trial sites. (XLS 16 kb)